vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $148.3M, roughly 1.1× Shoals Technologies Group, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 38.6%). Over the past eight quarters, Shoals Technologies Group, Inc.'s revenue compounded faster (27.8% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.
ESPR vs SHLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $148.3M |
| Net Profit | — | $8.1M |
| Gross Margin | — | 31.6% |
| Operating Margin | 50.6% | 11.7% |
| Net Margin | — | 5.5% |
| Revenue YoY | 143.7% | 38.6% |
| Net Profit YoY | — | 3.9% |
| EPS (diluted) | $0.32 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $148.3M | ||
| Q3 25 | $87.3M | $135.8M | ||
| Q2 25 | $82.4M | $110.8M | ||
| Q1 25 | $65.0M | $80.4M | ||
| Q4 24 | $69.1M | $107.0M | ||
| Q3 24 | $51.6M | $102.2M | ||
| Q2 24 | $73.8M | $99.2M | ||
| Q1 24 | $137.7M | $90.8M |
| Q4 25 | — | $8.1M | ||
| Q3 25 | $-31.3M | $11.9M | ||
| Q2 25 | $-12.7M | $13.9M | ||
| Q1 25 | $-40.5M | $-282.0K | ||
| Q4 24 | — | $7.8M | ||
| Q3 24 | $-29.5M | $-267.0K | ||
| Q2 24 | $-61.9M | $11.8M | ||
| Q1 24 | $61.0M | $4.8M |
| Q4 25 | — | 31.6% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 37.2% | ||
| Q1 25 | — | 35.0% | ||
| Q4 24 | — | 37.6% | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | — | 40.3% | ||
| Q1 24 | — | 40.2% |
| Q4 25 | 50.6% | 11.7% | ||
| Q3 25 | -11.4% | 13.7% | ||
| Q2 25 | 8.6% | 14.4% | ||
| Q1 25 | -34.0% | 5.4% | ||
| Q4 24 | -6.4% | 15.4% | ||
| Q3 24 | -31.0% | 4.4% | ||
| Q2 24 | 3.5% | 18.7% | ||
| Q1 24 | 52.5% | 12.8% |
| Q4 25 | — | 5.5% | ||
| Q3 25 | -35.9% | 8.7% | ||
| Q2 25 | -15.4% | 12.5% | ||
| Q1 25 | -62.2% | -0.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | -57.2% | -0.3% | ||
| Q2 24 | -83.9% | 11.9% | ||
| Q1 24 | 44.3% | 5.3% |
| Q4 25 | $0.32 | $0.05 | ||
| Q3 25 | $-0.16 | $0.07 | ||
| Q2 25 | $-0.06 | $0.08 | ||
| Q1 25 | $-0.21 | $0.00 | ||
| Q4 24 | $-0.14 | $0.04 | ||
| Q3 24 | $-0.15 | $0.00 | ||
| Q2 24 | $-0.33 | $0.07 | ||
| Q1 24 | $0.34 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $7.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $600.0M |
| Total Assets | $465.9M | $904.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $7.3M | ||
| Q3 25 | $92.4M | $8.6M | ||
| Q2 25 | $86.1M | $4.7M | ||
| Q1 25 | $114.6M | $35.6M | ||
| Q4 24 | $144.8M | $23.5M | ||
| Q3 24 | $144.7M | $11.1M | ||
| Q2 24 | $189.3M | $3.2M | ||
| Q1 24 | $226.6M | $15.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $141.8M | ||
| Q4 24 | — | $141.8M | ||
| Q3 24 | — | $141.8M | ||
| Q2 24 | — | $146.8M | ||
| Q1 24 | — | $168.8M |
| Q4 25 | $-302.0M | $600.0M | ||
| Q3 25 | $-451.4M | $589.6M | ||
| Q2 25 | $-433.5M | $575.4M | ||
| Q1 25 | $-426.2M | $558.9M | ||
| Q4 24 | $-388.7M | $556.8M | ||
| Q3 24 | $-370.2M | $545.2M | ||
| Q2 24 | $-344.2M | $544.6M | ||
| Q1 24 | $-294.3M | $554.0M |
| Q4 25 | $465.9M | $904.1M | ||
| Q3 25 | $364.0M | $851.8M | ||
| Q2 25 | $347.1M | $795.0M | ||
| Q1 25 | $324.0M | $788.4M | ||
| Q4 24 | $343.8M | $793.1M | ||
| Q3 24 | $314.1M | $801.3M | ||
| Q2 24 | $352.3M | $788.4M | ||
| Q1 24 | $373.1M | $825.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.30× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-4.1M |
| Free Cash FlowOCF − Capex | — | $-11.3M |
| FCF MarginFCF / Revenue | — | -7.6% |
| Capex IntensityCapex / Revenue | 0.0% | 4.8% |
| Cash ConversionOCF / Net Profit | — | -0.50× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-4.1M | ||
| Q3 25 | $-4.3M | $19.4M | ||
| Q2 25 | $-31.4M | $-13.8M | ||
| Q1 25 | $-22.6M | $15.6M | ||
| Q4 24 | $-35.0M | $14.0M | ||
| Q3 24 | $-35.3M | $15.7M | ||
| Q2 24 | $-7.2M | $37.8M | ||
| Q1 24 | $53.8M | $12.9M |
| Q4 25 | — | $-11.3M | ||
| Q3 25 | — | $9.0M | ||
| Q2 25 | — | $-26.0M | ||
| Q1 25 | — | $12.3M | ||
| Q4 24 | — | $12.5M | ||
| Q3 24 | $-35.5M | $13.3M | ||
| Q2 24 | $-7.3M | $35.8M | ||
| Q1 24 | $53.8M | $10.4M |
| Q4 25 | — | -7.6% | ||
| Q3 25 | — | 6.6% | ||
| Q2 25 | — | -23.5% | ||
| Q1 25 | — | 15.4% | ||
| Q4 24 | — | 11.6% | ||
| Q3 24 | -68.7% | 13.0% | ||
| Q2 24 | -9.9% | 36.1% | ||
| Q1 24 | 39.0% | 11.4% |
| Q4 25 | 0.0% | 4.8% | ||
| Q3 25 | 0.0% | 7.7% | ||
| Q2 25 | 0.0% | 11.0% | ||
| Q1 25 | 0.0% | 4.0% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.3% | 2.3% | ||
| Q2 24 | 0.1% | 2.0% | ||
| Q1 24 | 0.1% | 2.7% |
| Q4 25 | — | -0.50× | ||
| Q3 25 | — | 1.63× | ||
| Q2 25 | — | -1.00× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.21× | ||
| Q1 24 | 0.88× | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SHLS
| System Solutions | $122.0M | 82% |
| Components | $26.3M | 18% |
